SyntheticMR’s product to be available in Fujifilm’s Synapse PACS solution to customers in Japan
SyntheticMR announced today that their product SyMRI can be integrated in Fujifilm’s PACS solution Synapse as an opt-in available to their customers in Japan. This enables healthcare providers with the Synapse PACS to utilize SyntheticMR’s advanced imaging solutions directly in their clinical workflow.
SyntheticMR’s solution SyMRI includes multiple contrast-weighted images and quantitative data from a single short MR scan. The possibility to utilize the technology directly in the healthcare providers’ PACS environment can help speed up their MRI workflow, improve patient throughput and at the same time gain objective decision support tools and actionable data.
“We are pleased to see that SyMRI will be seamlessly integrated in the users’ own clinical workflow,” says Yusuke Shimizu, Head of Sales Japan at SyntheticMR. “This helps customers of the Synapse PACS in Japan to get the most out of our imaging solutions and gain access to actionable quantitative data.”
“SyntheticMR strives to create products and solutions to support a faster MR workflow and support radiologists in their daily tasks,” says Ulrik Harrysson, CEO SyntheticMR. “The ability to access our product in their own PACS environment is key in this regard.”
For additional information, please contact Ulrik Harrysson, CEO, SyntheticMR AB, +46 70 529 29 87 ulrik.harrysson@syntheticmr.com
SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR AB has developed SyMRI®, delivering multiple, adjustable contrast images and quantitative data from a single 6-minute scan. The SyMRI product is available in different packages. SyMRI NEURO delivers multiple contrast images, tissue segmentations and quantitative data on the brain. SyMRI MSK provides multiple contrast images and quantitative data for MSK anatomies. SyMRI NEURO is CE-marked and FDA 510(k) cleared and SyMRI MSK is FDA 510(k) pending. SyMRI is a registered trademark in Europe and the USA. SyntheticMR is listed on the Spotlight Stock Market Exchange in Stockholm, Sweden.